Eledon Pharmaceuticals, Inc. (ELDN)
3.44
+0.03
(+0.88%)
USD |
NASDAQ |
Aug 25, 13:38
Eledon Pharmaceuticals Total Liabilities (Quarterly) : 54.06M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 54.06M |
| March 31, 2026 | 46.21M |
| December 31, 2025 | 100.82M |
| September 30, 2025 | 38.80M |
| June 30, 2025 | 38.88M |
| March 31, 2025 | 46.73M |
| December 31, 2024 | 111.30M |
| September 30, 2024 | 38.52M |
| June 30, 2024 | 128.98M |
| March 31, 2024 | 95.55M |
| December 31, 2023 | 118.69M |
| September 30, 2023 | 4.734M |
| June 30, 2023 | 6.836M |
| March 31, 2023 | 7.514M |
| December 31, 2022 | 8.61M |
| September 30, 2022 | 8.493M |
| June 30, 2022 | 5.327M |
| March 31, 2022 | 5.06M |
| December 31, 2021 | 6.553M |
| September 30, 2021 | 6.422M |
| June 30, 2021 | 5.784M |
| March 31, 2021 | 7.811M |
| December 31, 2020 | 6.589M |
| September 30, 2020 | 171.08M |
| June 30, 2020 | 1.145M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.975M |
| December 31, 2019 | 1.466M |
| September 30, 2019 | 1.852M |
| June 30, 2019 | 2.184M |
| March 31, 2019 | 3.522M |
| December 31, 2018 | 2.534M |
| September 30, 2018 | 1.603M |
| June 30, 2018 | 1.452M |
| March 31, 2018 | 1.619M |
| December 31, 2017 | 1.44M |
| September 30, 2017 | 2.40M |
| June 30, 2017 | 3.405M |
| March 31, 2017 | 2.467M |
| December 31, 2016 | 3.898M |
| September 30, 2016 | 6.464M |
| June 30, 2016 | 7.973M |
| March 31, 2016 | 6.303M |
| December 31, 2015 | 6.25M |
| September 30, 2015 | 5.708M |
| June 30, 2015 | 4.66M |
| March 31, 2015 | 5.754M |
| December 31, 2014 | 4.243M |
| September 30, 2014 | 5.372M |
| June 30, 2014 | 3.688M |
| March 31, 2014 | 2.673M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 7.175B |
| Viking Therapeutics, Inc. | 113.58M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 126.09M |
| Shareholders Equity (Quarterly) | 72.03M |
| Debt to Equity Ratio | 0.0065 |
| Current Ratio | 7.896 |
| Net Debt Paydown Yield | 0.03% |